iTeos Therapeutics Overview

Life ScienceCompany

Was iTeos Therapeutics formerly PE-backed?

Yes. iTeos Therapeutics was formerly owned by 1 private investor.

Where is iTeos Therapeutics headquartered?

iTeos Therapeutics is headquartered in Watertown, Massachusetts.

What is iTeos Therapeutics’ revenue?

iTeos Therapeutics disclosed revenue of 35M USD for 2024 and 13M USD for 2023.

What sector is iTeos Therapeutics in?

iTeos Therapeutics is a life science company.

When was iTeos Therapeutics founded?

iTeos Therapeutics was founded in 2011.

iTeos Therapeutics

iTeos Therapeutics, Inc.

321 Arsenal Street, Suite 301, Building 312,
Watertown, Massachusetts 02472
United States,
+339 217 0161
www.iteostherapeutics.com

iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients. iTeos Therapeutics leverages its deep understanding of the tumor microenvironment and immunosuppressive pathways to design novel product candidates with an aim to improve the clinical benefit of oncology therapies. iTeos Therapeutics was founded in 2011 and is based in Watertown, Massachusetts.



Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.